Christine Newman, M.S.N., RN
BSN - University of Michigan - Ann Arbor
MSN - University of Michigan - Ann Arbor
Neonatal Nurse Clinician/Practitioner
Salem-Shata, S, Peterson, L., Palmer, H., Clanton, M., Ezhuthachan, S., Luttrell, R., Newman, C., Westbury, R. “Barriers to First-Week Follow-Up of Newborns: Findings from Parent and Clinican Focus Groups”. Joint Commission Journal on Quality and Safety. November 2004, Vol. 30, No. 11, Pages 593-601.
Ezhuthachan SG and Newman CO. Representing HFH. Timing of Initial Surfactant Treatment for Infants 23-29 weeks’ gestation: Is Routine Practice evidence Based. Horbar J et al for the VON. Pediatrics. Vol 113; #6,June 2004
Beal, A., Chou, S., Palmer, H., Testa, M., Newman, C., Ezhuthachan, S., “The Changing Face of Race: Risk Factors for Neonatal Hyperbilirubinemia”. Pediatrics, Vol. 117:5, May 2006, pages 1618-1625.
Newman, Christine . “Little Things Really do Matter: Neonatal Intensive Care”. In Weinstein, S and Brooks, A. Nursing Without Borders, Values, Wisdom and Success Markers. Sigma Theta Tau International Honor Society of Nursing , 2007. Pages 186- 194.
A Phase 2b/3, Multicenter, Randomized, Double – Blind, Placebo Controlled Trial to Evaluate the Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight (VLBW) Neonates for the Prevention of Staphylococcal Sepsis, Biosynexsus Incorporated. 2009-2010.
•NUR 7225 Pathophysiology, Clinical Care and Management I